The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule

Biochimica et Biophysica Acta - General Subjects

Volumn 1427, Issue 2, 1999, Pages 307-314

  Festin, Stephen M ^a   Bennett, James A ^a   Fletcher, Paul W ^a   Jacobson, Herbert I ^a   Shaye, Daniel D ^a   Andersen, Thomas T ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Alpha fetoprotein; Growth regulation; Recombinant protein

Indexed keywords

ALPHA FETOPROTEIN; ANTIESTROGEN; COMPLEMENTARY DNA; ESTROGEN; ESTROGEN RECEPTOR; HYBRID PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BACULOVIRUS; CLONE; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; GROWTH REGULATION; HUMAN; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; UTERUS GROWTH;

ALPHA-FETOPROTEINS; ANIMALS; BACULOVIRIDAE; BINDING SITES; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HISTIDINE; HUMANS; MICE; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SPECTROPHOTOMETRY, ULTRAVIOLET; UTERUS;

EID: 0032915456     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(99)00030-6     Document Type: Article

References (28)

1. Bergstrand C.G., Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand. J. Clin. Lab. Invest. 8:1956;174.
2. Nishi S., Nishita T., Ohkawa K. Production of 13 plasma proteins by human testicular yolk sac tumor transplanted into nude mice. Tumor Biol. 12:1991;184-188.
3. Sell S., Alexander D. Rat AFP IV; catabolism and fetal-maternal distribution. J. Natl. Cancer Inst. 52:1974;1483-1489.
4. Hirai H., Nishi S., Watabe H., Tsukada I. Some chemical, experimental, and clinical investigations of AFP. Gann Mongr. Cancer Res. 14:1973;19-34.
5. Birkenmeier G., Shanbhag V.P., Kopperschlager G. Comparison of the binding of poly (ethyleneglycol)-bound fatty acids to human albumin and alpha-fetoprotein: Studies by affinity phase partitioning. Biomed. Biochim. Acta. 45:1986;235-289.
6. Berde C.B., Nagai M., Deutsch H.F. Human α-fetoprotein fluorescence studies on binding and proximity relationships for fatty acid and bilirubin. J. Biol. Chem. 254:1979;12609-12614.
7. Hirano K., Watanabe Y., Adachi T., Ito Y., Sugiura M. Drug-binding properties of human α-fetoprotein. Biochem. J. 231:1985;189-191.
8. E.A. Nunez, L. Benassayag, G. Savu, G. Vallette, M.F. Jayle, in: W.H. Fishman, S. Sell (Eds.), Onco-developmental Gene Expression, Academic Press, New York, 1976, pp. 365-372.
9. Mizejewski G.J., Vonnegut M., Jacobson H.I. Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens. Proc. Natl. Acad. Sci. USA. 80:1983;2733-2737.
10. H.I. Jacobson, D.T. Janerich, Pregnancy-altered breast cancer risk; mediated by maternal serum AFP? in: G.J. Mizejewski, H.I. Jacobson (Eds.), Biological Activities of Alpha-fetoprotein, Vol. 2, CRC Press, Boca Raton, FL, 1989, pp. 93-100.
11. Morinaga T., Sakai M., Wegmann T.G., Tamaoki T. Primary structures of human alpha-fetoprotein and its mRNA. Proc. Natl. Acad. Sci. USA. 80:1983;4604-4608.
12. Law S.W., Dugaiczyk A. Homology between the primary structure of alpha-fetoprotein, deduced from a complete cDNA sequence, and serum albumin. Nature. 291:1981;201-205.
13. Soda M. Cloning and expression of rat alpha-fetoprotein cDNA in Escherichia coli. Hokkaido Igaku Zasshi. 65:1990;510-516.
14. Carter D.C., He X., Munson S.H., Twigg P.D., Gernert K.M., Broom M.B., Miller T.Y. Three-dimensional structure of human serum albumin. Science. 244:1989;1195-1198.
15. He X.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature. 358:1992;209-215.
16. Baker M.E. Evolution of alpha-fetoprotein: sequence comparisons among AFP species and with albumin species. Tumor Biol. 9:1988;123-136.
17. Gorin M.B., Cooper D.L., Eiferman F., van de Rijn P., Tilghman S.M. The evolution of alpha-fetoprotein and albumin. J. Biol. Chem. 256:1981;1954-1959.
18. Jacobson H.I., Marotta D., Mizejewski G.J., Bennett J.A., Andersen T.T. Estradiol-induced changes in spectral and biological properties of alpha-fetoprotein. Tumor Biol. 11:1990;104.
19. Allen S.H.G., Bennett J.A., Mizejewski G.J., Andersen T.T., Ferraris S., Jacobson H.I. Purification of alpha-fetoprotein from human cord serum with demonstration of its antiestrogenic activity. Biochim. Biophys. Acta. 1202:1993;135-142.
20. Soloff M.S., Creange J.E., Potts G.O. Unique estrogen-binding properties of rat pregnancy plasma. Endocrinology. 88:1971;427-432.
21. Swartz S.K., Soloff M.S. The lack of estrogen binding by human α-fetoprotein. J. Clin. Endocrinol. Metab. 39:1974;589-591.
22. Jacobson H.I., Bennett J.A., Mizejewski G.J. Inhibition of estrogen-dependent breast cancer growth by a reaction product of α-fetoprotein and estradiol. Cancer Res. 50:1990;415-420.
23. D.R. O'Reilly, L.K. Miller, V.A. Luckow, Baculovirus Expression Vectors: a Laboratory Manual, Freeman, New York, 1992.
24. T.T. Herskovits, Difference spectroscopy, in: C.H.W. Hirs (Ed.), Methods in Enzymology, Academic Press, New York, 1967, pp. 748-775.
25. Dudich I.V., Semenkova L.N., Gorbatova E.A., Dudich E.I. Effect of AFP dimerization and ligand binding on the AFP-mediated cell growth regulative activity. Tumor Biol. 18:(Suppl. 2):1997;101.
26. Bennett J.A., Zhu S.J., Pagano-Mirarchi A., Kellom T.A., Jacobson H.I. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts. J. Clin. Cancer Res. 4:1998;2877-2884.
27. Bennett J.A., Semeniuk D.J., Jacobson H.I., Murgita R.A. Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth. Breast Cancer Res. Treat. 45:1997;169-179.
28. Mizejewski G.J., Dias J.A., Hauer C.R., Henrikson K.P., Gierthy J. Alpha-fetoprotein derived synthetic peptides: assay of an estrogen modifying regulatory segment. Mol. Cell. Endocrinol. 118:1996;15-23.